Abbott India Limited has announced the outcome of its Board Meeting held on November 5, 2026. The Board approved the unaudited financial results for the quarter and half year ended September 30, 2026. The company also presented the Limited Review Report from its statutory auditors, Walker Chandiok & Co. LLP. The financial statements indicate total income of ₹2,019.07 crore for the quarter ended September 30, 2026, with profit after tax at ₹453.45 crore.
Abbott India Board Approves Financial Results
On November 5, 2026, the Board of Directors of Abbott India Limited convened to review and approve the company’s financial performance. The Board sanctioned the unaudited financial results for the quarter and the six-month period that concluded on September 30, 2026. This approval was made in compliance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Key Financial Highlights
The unaudited financial results for the quarter ended September 30, 2026, show a total income of ₹2,019.07 crore, an increase from the ₹1,889.05 crore reported in the previous year’s corresponding quarter. The profit after tax for the quarter stood at ₹453.45 crore, compared to ₹415.27 crore in the same period of the previous year. For the six months ended September 30, 2026, the total income was ₹3,908.12 crore, with a profit after tax of ₹881.97 crore.
Statutory Auditor’s Report
Accompanying the financial results is the Limited Review Report issued by Walker Chandiok & Co. LLP, the company’s Statutory Auditors. The report confirms the limited review of the unaudited financial results for the quarter and six months ended September 30, 2026, and states that it does not contain any qualifications.
Board Meeting Details
The Board meeting commenced at 4:00 PM and concluded at 6:30 PM on November 5, 2026. The company operates in a single segment, ‘Pharmaceuticals’, rendering segment-specific disclosures inapplicable.
Source: BSE
